Medigen Vaccine Biologics Corporation (TPEX:6547)
Taiwan · Delayed Price · Currency is TWD 40.45
-0.75 (-1.82%)
At close: Dec 5, 2025
Medigen Vaccine Biologics Market Cap
Medigen Vaccine Biologics has a market cap or net worth of 13.3 billion as of December 5, 2025. Its market cap has increased by 5.22% in one year.
Market Cap
13.30B
Enterprise Value
11.92B
Revenue
594.96M
Ranking
n/a
PE Ratio
n/a
Stock Price
40.45
Market Cap Chart
Since August 6, 2015, Medigen Vaccine Biologics's market cap has increased from 2.83B to 13.30B, an increase of 369.06%. That is a compound annual growth rate of 16.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 13.30B | 12.21% |
| Dec 31, 2024 | 11.85B | -48.55% |
| Dec 29, 2023 | 23.04B | 1.10% |
| Dec 30, 2022 | 22.78B | -64.20% |
| Dec 30, 2021 | 63.65B | 192.75% |
| Dec 31, 2020 | 21.74B | 388.97% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 283.81B |
| PharmaEssentia | 191.95B |
| Lotus Pharmaceutical | 78.37B |
| Bora Pharmaceuticals Co., LTD. | 65.31B |
| Oneness Biotech | 33.97B |
| Lin BioScience | 33.46B |
| Lumosa Therapeutics | 32.77B |
| Center Laboratories | 27.88B |